Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results
Jason Bacharach,1 David L Wirta,2 Robert Smyth-Medina,3 Michael S Korenfeld,4 Shane R Kannarr,5 Shane Foster,6 Mark J Jaros,7 Charles B Slonim8 1North Bay Eye Associates, Petaluma, CA, USA; 2Aesthetic Eye Care Institute & Eye Research Foundation, Newport Beach, CA, USA; 3North Valley Eye Medical...
Guardado en:
Autores principales: | Bacharach J, Wirta DL, Smyth-Medina R, Korenfeld MS, Kannarr SR, Foster S, Jaros MJ, Slonim CB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf630f6b36144f9b8a9db37d4c1f1f1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials
por: Wirta DL, et al.
Publicado: (2021) -
Infarto perioperatorio en cirugía no-cardíaca y dexmedetomidina
por: Ibacache,Mauricio, et al.
Publicado: (2010) -
Effect of Dexmedetomidine on Perioperative Haemodynamic Fluctuations in Untreated Stage 1 Hypertensive Patients Undergoing Laparoscopic Cholecystectomy - A Randomised Controlled Trial
por: anish kumar singh, et al.
Publicado: (2021) -
Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
por: Chen Bin, et al.
Publicado: (2021) -
A step-up ractopamine feeding program for finishing pigs
por: Tiago L. Holzback, et al.
Publicado: (2018)